|Daily Range||$22.75 - $23.82|
|52-Week Range||$13.33 - $29.83|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||139,777|
|Current FY EPS||-$2.89|
ONCOMED PHARMACEUTICALS INC (OMED) Description
ONCOMED PHARMACEUTICALS INC Website: http://www.oncomed.com/
The healthcare sector is packed with high-growth, but risky, investment opportunities. However, this healthcare stock appears to have all your bases covered.
Annual global cancer incidence rates are expected to rise by nearly 60% in the next 20 years, prompting drug developers to get creative in their fight against cancer.
OncoMed Presents Positive Immuno-Oncology Data for Combined Blockade of DLL4, VEGF and PD1 at SITC Conference
OncoMed Pharmaceuticals (OMED) Jumps: Stock Rises 5.4% - Tale of the Tape